Operating income before deduction of amortization: cassavasciences.com (SAVA)
Cassava Sciences, Inc. (SAVA) is awaiting the results of key Alzheimer's therapy tests to overcome regulatory skepticism. The EBITDA trend visualization on the GURU.Markets website confirms volatility, with the metric standing at 0.00. Successful development would grant the company total pricing power, yet ongoing disputes regarding data integrity create extreme operational risks for management.
Cassava - analytical breakdowns and key metrics (SAVA)
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Capital Cassava Sciences, Inc.|SAVA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Cassava Pharma|SAVA - Company Debts|Debts to Net Assets Cassava Sciences, Inc.|SAVA - Company Long-Term Debts|Company Current Liabilities Cassava Sciences|Interim Coverage Ratio cassavasciences.com
- business earnings and investment ratios data:
SAVA - Net Profit|Expected Net Profit Cassava Sciences, Inc.|SAVA - Price to Earnings Ratio|Price to Future Earnings Ratio Cassava Sciences|SAVA - PEG Multiple|Enterprise Value to EBITDA Ratio Cassava Sciences, Inc.|SAVA - Operating profit EBITDA|Net earnings per one share for the last twelve months Cassava Sciences|SAVA - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months cassavasciences.com|SAVA - Net earnings per share growth this year|Expected earnings per share trend next year Cassava Sciences, Inc.
- sales and revenue indicators:
Analysis of all company metrics:SAVA Cassava Sciences, Inc.
Professional capital assesses the profile of Cassava Sciences, Inc. (SAVA) through the business's ability to generate cash flow from core operations, excluding the impact of loans and taxes. By analyzing the recorded EBITDA level on the GURU.Markets platform, the investor sees the actual volume of operating funds, which for this biotech is critically low, as the company is effectively depleting its existing reserves on costly clinical trials.
Who Cassava Sciences, Inc. competes with
Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX - Operating profit before depreciation charges|Operating profit before deduction of amortization SUPN (supernus.com)|Operating income before deduction of amortization Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Operating profit EBITDA|Operating profit before amortization CBLL (CeriBell Corp)|Profit before payment of interest, taxes and amortization Prothena Biosciences (PRTA)|Operating income before deduction of amortization Alector|Operating profit EBITDA ANNX (annexonbio.com)|Income before deduction of interest, taxes and amortization OMER|NGNE: Operating profit before deduction of amortization|ACIU (AC Immune Corp) - Operating profit before amortization|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Operating profit EBITDA|Operating profit before amortization TVGN (Tevogen Bio)|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Inhibikase Pharma - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ASRT|Coya Therapeutics Inc - Operating profit EBITDA|Operating income before deduction of amortization vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals, Inc (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc.|Alterity Therapeutics (ATHE) - Operating income before deduction of amortization|Operating profit EBITDA CLNN|PEPG - Profit before interest, taxes and amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences, Inc.)|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Grace Therapeutics (GRCE)|AIFF: Operating profit EBITDA|ANEW Medical, Inc. (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd.|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis (NRXS)|Helius Medical Technologies, Inc. - Operating profit before deduction of amortization|Operating income before deduction of amortization Passage Bio, Inc. (PASG)|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva)|ATHA: Operating profit EBITDA|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|Profit before interest, taxes and amortization Cyclerion Therapeutics CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit EBITDA Pasithea Therapeutics Corp (KTTA)|Cortigent, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Avenue Therapeutics ATXI|BCLI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CARA (Cara Therapeutics)|Chromocell Therapeutics Corporation (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before interest, taxes and amortization longboardpharma.com LBPH|Profit before payment of interest, taxes and amortization Marinus (MRNS)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo)|Income before deduction of interest, taxes and amortization SAGE|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel
